Literature DB >> 12909620

Modulation of notch-ligand binding by protein O-fucosyltransferase 1 and fringe.

Tetsuya Okajima1, Aiguo Xu, Kenneth D Irvine.   

Abstract

Notch receptors are glycoproteins that mediate a wide range of developmental processes. Notch is modified in its epidermal growth factor-like domains by the addition of fucose to serine or threonine residues. O-Fucosylation is mediated by protein O-fucosyltransferase 1, and down-regulation of this enzyme by RNA interference or mutation of the Ofut1 gene in Drosophila or by mutation of the Pofut1 gene in mouse prevents Notch signaling. To investigate the molecular basis for the requirement for O-linked fucose on Notch, we assayed the ability of tagged, soluble forms of the Notch extracellular domain to bind to its ligands, Delta and Serrate. Down-regulation of OFUT1 by RNA interference in Notch-secreting cells inhibits both Delta-Notch and Serrate-Notch binding, demonstrating a requirement for O-linked fucose for efficient binding of Notch to its ligands. Conversely, overexpression of OFUT1 in cultured cells increases Serrate-Notch binding but inhibits Delta-Notch binding. These effects of OFUT1 are consistent with the consequences of OFUT1 overexpression on Notch signaling in vivo. Intriguingly, they are also opposite to, and are suppressed by, expression of the glycosyltransferase Fringe, which specifically modifies O-linked fucose. Thus, Notch-ligand interactions are dependent upon both the presence and the type of O-fucose glycans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909620     DOI: 10.1074/jbc.M308687200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  85 in total

1.  Interaction between Notch and Hif-alpha in development and survival of Drosophila blood cells.

Authors:  Tina Mukherjee; William Sang Kim; Lolitika Mandal; Utpal Banerjee
Journal:  Science       Date:  2011-06-03       Impact factor: 47.728

Review 2.  Notch signaling in mammary development and oncogenesis.

Authors:  Robert Callahan; Sean E Egan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

Review 3.  Expression of human glycosyltransferase genes in yeast as a tool for enzymatic synthesis of sugar chain.

Authors:  Yoh-ichi Shimma; Yoshifumi Jigami
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 4.  Role of glycans and glycosyltransferases in the regulation of Notch signaling.

Authors:  Hamed Jafar-Nejad; Jessica Leonardi; Rodrigo Fernandez-Valdivia
Journal:  Glycobiology       Date:  2010-04-05       Impact factor: 4.313

Review 5.  Notch ligand endocytosis: mechanistic basis of signaling activity.

Authors:  Abdiwahab A Musse; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Semin Cell Dev Biol       Date:  2012-01-24       Impact factor: 7.727

6.  The glycosylation pathway is required for the secretion of Slit and for the maintenance of the Slit receptor Robo on axons.

Authors:  Mary Ann Manavalan; Vatsala Ruvini Jayasinghe; Rickinder Grewal; Krishna Moorthi Bhat
Journal:  Sci Signal       Date:  2017-06-20       Impact factor: 8.192

7.  Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1.

Authors:  Liang-Tung Yang; James T Nichols; Christine Yao; Jennifer O Manilay; Ellen A Robey; Gerry Weinmaster
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

8.  A protease storm cleaves a cell-cell adhesion molecule in cancer: multiple proteases converge to regulate PTPmu in glioma cells.

Authors:  Polly J Phillips-Mason; Sonya E L Craig; Susann M Brady-Kalnay
Journal:  J Cell Biochem       Date:  2014-09       Impact factor: 4.429

Review 9.  Role of unusual O-glycans in intercellular signaling.

Authors:  Kelvin B Luther; Robert S Haltiwanger
Journal:  Int J Biochem Cell Biol       Date:  2008-10-08       Impact factor: 5.085

Review 10.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.